We are live on ! Find out more
LIA

LS Investment Advisors Portfolio holdings

AUM $738M
1-Year Est. Return 29.35%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+29.35%
3 Year Est. Return
+85.73%
5 Year Est. Return
+98.39%
10 Year Est. Return
+364.74%
AUM
$1.23B
AUM Growth
+$71.4M
Cap. Flow
+$13M
Cap. Flow %
1.05%
Top 10 Hldgs %
17.96%
Holding
1,025
New
30
Increased
409
Reduced
156
Closed
30

Top Buys

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$2.48M
2
AMGN icon
Amgen
AMGN
+$1.98M
3
VZ icon
Verizon
VZ
+$1.3M
4
BIIB icon
Biogen
BIIB
+$1.28M
5
MAC icon
Macerich
MAC
+$1.24M

Sector Composition

Rank Sector Weight
1 Healthcare 16.68%
2 Financials 14.46%
3 Technology 13.57%
4 Industrials 9.41%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
26
Ford
F
$60.9B
$12.3M 1%
795,391
-376
-0% -$5.54K
SEE
27
DELISTED
Sealed Air
SEE
$12.2M 0.99%
288,120
+17,903
+7% +$673K
XOM icon
28
ExxonMobil
XOM
$650B
$12.1M 0.98%
130,810
+4,274
+3% +$399K
JCI icon
29
Johnson Controls International
JCI
$85.1B
$12.1M 0.98%
238,692
+3,441
+1% +$168K
ORCL icon
30
Oracle
ORCL
$339B
$12M 0.97%
267,487
+4,285
+2% +$174K
EOG icon
31
EOG Resources
EOG
$77.7B
$12M 0.97%
129,995
+1,045
+0.8% +$97.3K
LYB icon
32
LyondellBasell Industries
LYB
$19.5B
$11.3M 0.91%
141,721
+2,001
+1% +$174K
CVX icon
33
Chevron
CVX
$382B
$10.8M 0.88%
96,698
+3,348
+4% +$380K
EG icon
34
Everest Group
EG
$15.6B
$10.1M 0.82%
59,092
+200
+0.3% +$33.8K
MMM icon
35
3M
MMM
$91.8B
$9.69M 0.79%
70,534
+109
+0.2% +$14K
PG icon
36
Procter & Gamble
PG
$340B
$9.52M 0.77%
104,489
-1,665
-2% -$146K
NVS icon
37
Novartis
NVS
$302B
$9.45M 0.77%
113,795
+393
+0.3% +$32.6K
KO icon
38
Coca-Cola
KO
$383B
$9.41M 0.76%
222,924
-5,614
-2% -$240K
SLB icon
39
SLB Ltd
SLB
$72.7B
$9.27M 0.75%
108,568
+372
+0.3% +$34.2K
INTC icon
40
Intel
INTC
$413B
$7.13M 0.58%
196,466
+6,567
+3% +$228K
JNJ icon
41
Johnson & Johnson
JNJ
$640B
$7.02M 0.57%
67,150
+89
+0.1% +$9.38K
GE icon
42
GE Aerospace
GE
$364B
$6.96M 0.56%
57,445
+2,661
+5% +$327K
USB icon
43
US Bancorp
USB
$97.9B
$6.79M 0.55%
151,117
+9,572
+7% +$412K
MSFT icon
44
Microsoft
MSFT
$2.9T
$6.09M 0.49%
131,047
+6,252
+5% +$293K
VEA icon
45
Vanguard FTSE Developed Markets ETF
VEA
$223B
$5.95M 0.48%
156,979
+3,486
+2% +$135K
KMB icon
46
Kimberly-Clark
KMB
$37.6B
$5.72M 0.46%
49,552
-1,404
-3% -$156K
MCD icon
47
McDonald's
MCD
$193B
$5.61M 0.45%
59,861
+2,323
+4% +$217K
VWO icon
48
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$5.48M 0.44%
136,959
-42,538
-24% -$1.75M
ABT icon
49
Abbott
ABT
$187B
$5.37M 0.44%
119,359
+15,900
+15% +$693K
ABBV icon
50
AbbVie
ABBV
$465B
$5.33M 0.43%
81,460
-7,618
-9% -$480K

Similar funds

LS Investment Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, LS Investment Advisors held 1,025 positions worth $1.23B, up 6.1% from $1.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LS Investment Advisors's Q4 2014 filing shows 30 new, 409 increased, 156 reduced and 30 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 12,600 shares worth $593K. The largest sale was Occidental Petroleum, an estimated $6.33M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

  • LS Investment Advisors's largest Q4 2014 buy was iShares Core MSCI Emerging Markets ETF: 12,600 shares worth $593K.
  • LS Investment Advisors added most to Kinder Morgan in Q4 2014, an estimated $2.48M increase.
  • LS Investment Advisors's biggest Q4 2014 reduction was Occidental Petroleum, cutting an estimated $6.33M.
  • LS Investment Advisors fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $1.44M.
  • LS Investment Advisors's ten largest holdings make up 18% of its $1.23B portfolio in Q4 2014.
  • LS Investment Advisors opened 30 new positions and closed 30 in Q4 2014.
  • LS Investment Advisors's portfolio value rose 6.1% quarter-over-quarter to $1.23B.

Based on LS Investment Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.